Display options
Share it on

Cent European J Urol. 2014;67(3):282-6. doi: 10.5173/ceju.2014.03.art14. Epub 2014 Aug 18.

The evaluation of tissue mass loss in the incision line of prostate with benign hyperplasia performed using holmium laser and cutting electrode.

Central European journal of urology

Mariusz Szewczyk, Dorota Jesionek-Kupnicka, Marek Ireneusz Lipiński, Piotr Lipinski, Waldemar Różański

Affiliations

  1. 2 Clinic of Urology, Medical University of ?ód?, Poland.
  2. Pathology Unit and Department of Oncology, Medical University of ?ód?, Poland.

PMID: 25247088 PMCID: PMC4165671 DOI: 10.5173/ceju.2014.03.art14

Abstract

INTRODUCTION: The aim of this study is to compare the changes in the incision line of prostatic adenoma using a monopolar cutting electrode and holmium laser, as well as the assessment of associated tissue mass and volume loss of benign prostatic hyperplasia (BPH).

MATERIAL AND METHODS: The material used in this study consisted of 74 preparations of prostatic adenoma obtained via open retropubic adenomectomy, with an average volume of 120.7 ml. The material obtained cut in vitro before fixation in formaldehyde. One lobe was cut using holmium laser, the other using a monopolar cutting electrode. After the incision was made, tissue mass and volume loss were evaluated. Thermocoagulation changes in the incision line were examinedunder light microscope.

RESULTS: In the case of the holmium laser incision, the average tissue mass loss was 1.73 g, tissue volume loss 3.57 ml and the depth of thermocoagulation was 1.17 mm. When the monopolar cutting electrode was used average tissue mass loss was 0.807 g, tissue volume loss 2.48 ml and the depth of thermocoagulation was 0.19 mm.

CONCLUSIONS: Where holmium laser was used, it was observed that the layer of tissue with thermocoagulation changes was deeper than in the case of the monopolar cutting electrode. Moreover, it was noticed that holmium laser caused bigger tissue mass and volume loss than the cutting electrode.

Keywords: BPH; TURP; holmium laser; mass loss; prostate

References

  1. Eur Urol. 2011 Oct;60(4):734-9 - PubMed
  2. Cent European J Urol. 2011;64(1):26-9 - PubMed
  3. Eur Urol. 2006 Nov;50(5):969-79; discussion 980 - PubMed
  4. J Urol. 1989 Feb;141(2):243-7 - PubMed
  5. Scand J Urol Nephrol. 2003;37(6):494-7 - PubMed
  6. J Urol. 2005 Sep;174(3):998-1001; discussion 1001 - PubMed
  7. J Endourol. 2003 Oct;17(8):595-600 - PubMed
  8. BJU Int. 2007 Jul;100(1):94-101 - PubMed
  9. Urology. 2005 Nov;66(5 Suppl):108-13 - PubMed
  10. J Urol. 2006 Apr;175(4):1428-32 - PubMed
  11. BJU Int. 2005 Oct;96(5):736-9 - PubMed
  12. BJU Int. 1999 Jul;84(1):1-9 - PubMed
  13. J Urol. 1990 Mar;143(3):533-7 - PubMed
  14. Urology. 1998 Apr;51(4):573-7 - PubMed
  15. Eur Urol. 2008 Feb;53(2):382-89 - PubMed
  16. Eur Urol. 2007 Nov;52(5):1465-71 - PubMed
  17. Eur Urol. 2013 May;63(5):859-67 - PubMed
  18. Eur Urol. 2006 Sep;50(3):563-8 - PubMed
  19. Eur Urol. 2008 Jan;53(1):160-6 - PubMed
  20. J Endourol. 2000 Jun;14(5):459-62 - PubMed
  21. Br J Urol. 1998 May;81(5):712-20 - PubMed
  22. J Endourol. 1998 Oct;12(5):457-9 - PubMed
  23. Eur Urol. 2005 Dec;48(6):965-71; discussion 972 - PubMed
  24. Asian J Androl. 2009 May;11(3):277-81 - PubMed
  25. J Urol. 2004 Aug;172(2):616-9 - PubMed
  26. Int J Urol. 2004 Nov;11(11):978-82 - PubMed
  27. Eur Urol. 2006 Jun;49(6):961-9 - PubMed
  28. Urology. 2005 Oct;66(4):789-93 - PubMed

Publication Types